Skip to main content
Erschienen in: Supportive Care in Cancer 2/2014

01.02.2014 | Original Article

The role of interpersonal relationships in men's attendance in primary care: qualitative findings in a cohort of men with prostate cancer

verfasst von: Liz Forbat, Morag Place, Gill Hubbard, Hing Leung, Daniel Kelly

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Men's response to ill health is framed as a “battleground” for the enactment of masculinities. With an increase in diagnoses of men's cancers, there is a need to better understand the features which influence timely access to diagnostic services. This study explored the ways in which men account for the timing of their diagnosis of prostate cancer.

Methods

Thirty semi-structured interviews were conducted with men and, where possible, their partner. Data were analyzed with reference to framework analysis.

Results

Relationships, including spousal, familial, and friendships, appear pivotal in informing men's help-seeking behaviors. Friends and partners were often critical in facilitating access to primary care. Following their own diagnosis, this virtuous cycle of encouragement led many men to encourage others to seek medical attention for prostate tests.

Conclusions

Interpersonal relationships are a missing dimension in models of delay. We need to know more about how to use relationships, in addition to traditional routes, to harness health promotion messages. Interpersonal relationship, including partners and social networks, may be powerful conduits and may prove effective mechanisms to identify and access men most at risk of prostate cancer.
Literatur
2.
Zurück zum Zitat ISD Scotland (2009) Cancer in Scotland (2009) Edinburgh, NHS National Services Scotland. Ref type: report ISD Scotland (2009) Cancer in Scotland (2009) Edinburgh, NHS National Services Scotland. Ref type: report
3.
Zurück zum Zitat Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581–591PubMedCrossRef Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581–591PubMedCrossRef
4.
Zurück zum Zitat National Cancer Institute UNIoH (2010) Age-adjusted SEER incidence rates and trends for the top 15 cancer sites by race/ethnicity. National Cancer Institute UNIoH, editor. SEER Cancer Statistics Review 1975–2007. Surveillance Epidemiology and End Results (SEER). Bethesda, MD. Ref type: generic National Cancer Institute UNIoH (2010) Age-adjusted SEER incidence rates and trends for the top 15 cancer sites by race/ethnicity. National Cancer Institute UNIoH, editor. SEER Cancer Statistics Review 1975–2007. Surveillance Epidemiology and End Results (SEER). Bethesda, MD. Ref type: generic
7.
Zurück zum Zitat Mistry M, Parkin DM, Ahmad AS, Sasieni P (2011) Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer 105:1795–1803PubMedCentralPubMedCrossRef Mistry M, Parkin DM, Ahmad AS, Sasieni P (2011) Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer 105:1795–1803PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Ablin RJ, Haythorn MR (2009) Screening for prostate cancer: controversy? what controversy? Curr Oncol 16(3):142–143CrossRef Ablin RJ, Haythorn MR (2009) Screening for prostate cancer: controversy? what controversy? Curr Oncol 16(3):142–143CrossRef
9.
Zurück zum Zitat Barry MJ (2009) Screening for prostate cancer—the controversy that refuses to die. N Engl J Med 360(13):1351–1354PubMedCrossRef Barry MJ (2009) Screening for prostate cancer—the controversy that refuses to die. N Engl J Med 360(13):1351–1354PubMedCrossRef
10.
Zurück zum Zitat Schroeder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13):1320–1328CrossRef Schroeder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13):1320–1328CrossRef
11.
Zurück zum Zitat Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA et al (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut Int J Gastroenterol Hepatol 47(4):533–538 Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA et al (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut Int J Gastroenterol Hepatol 47(4):533–538
12.
Zurück zum Zitat Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid TCJ et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106:416–422PubMedCrossRef Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid TCJ et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106:416–422PubMedCrossRef
13.
Zurück zum Zitat Andersen BL, Cacioppo JT, Roberts DC (1995) Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol 34(1):33–52PubMedCrossRef Andersen BL, Cacioppo JT, Roberts DC (1995) Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol 34(1):33–52PubMedCrossRef
14.
Zurück zum Zitat Walter F, Webster A, Scott S, Emery J (2011) The Andersen Model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Service Res Policy 17(2):110–118CrossRef Walter F, Webster A, Scott S, Emery J (2011) The Andersen Model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Service Res Policy 17(2):110–118CrossRef
15.
Zurück zum Zitat Fitzpatrick P, Corcoran N, Fitzpatrick JM (1998) Prostate cancer: how aware is the public? Br J Urol 82(1):43–48PubMedCrossRef Fitzpatrick P, Corcoran N, Fitzpatrick JM (1998) Prostate cancer: how aware is the public? Br J Urol 82(1):43–48PubMedCrossRef
16.
Zurück zum Zitat Hevey D, Pertl M, Thomas K, Maher L, Chuinneagain SN, Craig A (2009) The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men. Patient Educ Couns 74(2):244–249PubMedCrossRef Hevey D, Pertl M, Thomas K, Maher L, Chuinneagain SN, Craig A (2009) The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men. Patient Educ Couns 74(2):244–249PubMedCrossRef
17.
Zurück zum Zitat Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. EJC 36(2):235–241CrossRef Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. EJC 36(2):235–241CrossRef
18.
Zurück zum Zitat Forbat L, Place M, Kelly D, Hubbard G, Boyd K, Howie K et al (2012) A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing. Br J Urol Int 111(3):389–395CrossRef Forbat L, Place M, Kelly D, Hubbard G, Boyd K, Howie K et al (2012) A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing. Br J Urol Int 111(3):389–395CrossRef
19.
Zurück zum Zitat Smith LK, Pope C, Botha JL (2005) Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366(9488):825–831PubMedCrossRef Smith LK, Pope C, Botha JL (2005) Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366(9488):825–831PubMedCrossRef
20.
Zurück zum Zitat George A, Flemming P (2004) Factors affecting men's help-seeking in the early detection of prostate cancer: implications for health promotion. J Men's Health Gender 1(4):345–352 George A, Flemming P (2004) Factors affecting men's help-seeking in the early detection of prostate cancer: implications for health promotion. J Men's Health Gender 1(4):345–352
21.
Zurück zum Zitat Ndubuisi SC, Kofie VY, Andoy JY et al (1995) Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology 46:71–77PubMedCrossRef Ndubuisi SC, Kofie VY, Andoy JY et al (1995) Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology 46:71–77PubMedCrossRef
22.
Zurück zum Zitat Krongrad A, Lai H, Burke MA et al (1996) Marriage and mortality in prostate cancer. J Urol 156:1696–1700PubMedCrossRef Krongrad A, Lai H, Burke MA et al (1996) Marriage and mortality in prostate cancer. J Urol 156:1696–1700PubMedCrossRef
23.
Zurück zum Zitat Tyson M, Andrews P, Etzioni D, et al. (2012) Marital status and prostate cancer outcomes. American Urological Association Annual Meeting. 19-5-2012. Ref type: conference proceeding Tyson M, Andrews P, Etzioni D, et al. (2012) Marital status and prostate cancer outcomes. American Urological Association Annual Meeting. 19-5-2012. Ref type: conference proceeding
24.
Zurück zum Zitat Seymour-Smith S, Wetherell M, Pheonix A (2002) ‘My wife ordered me to come!’: a discursive analysis of doctors' and nurses' accounts of men's use of general practitioners. J Health Psychol 7(3):253–267PubMedCrossRef Seymour-Smith S, Wetherell M, Pheonix A (2002) ‘My wife ordered me to come!’: a discursive analysis of doctors' and nurses' accounts of men's use of general practitioners. J Health Psychol 7(3):253–267PubMedCrossRef
25.
Zurück zum Zitat Courtenay WH (2005) Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med 50:1385–1401CrossRef Courtenay WH (2005) Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med 50:1385–1401CrossRef
26.
Zurück zum Zitat O'Brien R, Hunt K, Hart G (2005) ‘It's caveman stuff, but that is to a certain extent how guys still operate’: men's accounts of masculinity and help seeking. Soc Sci Med 61(3):503–516PubMedCrossRef O'Brien R, Hunt K, Hart G (2005) ‘It's caveman stuff, but that is to a certain extent how guys still operate’: men's accounts of masculinity and help seeking. Soc Sci Med 61(3):503–516PubMedCrossRef
27.
Zurück zum Zitat Nicholas DR (1990) Men, masculinity and cancer: risk-factor behaviours, early detection and psychosocial adaptation. J Am Coll Health 49(1):27–33CrossRef Nicholas DR (1990) Men, masculinity and cancer: risk-factor behaviours, early detection and psychosocial adaptation. J Am Coll Health 49(1):27–33CrossRef
28.
Zurück zum Zitat Creswell JW, Plano Clark VL (2006) Designing and conducting mixed methods research. Sage, London Creswell JW, Plano Clark VL (2006) Designing and conducting mixed methods research. Sage, London
29.
Zurück zum Zitat Irvine A, Drew P, Sainsbury R (2012) ‘Am I not answering your questions properly?’: clarification, adequacy and responsiveness in semi-structured telephone and face-to-face interviews. Qual Health Res. doi:10.1177/1468794112439086 Irvine A, Drew P, Sainsbury R (2012) ‘Am I not answering your questions properly?’: clarification, adequacy and responsiveness in semi-structured telephone and face-to-face interviews. Qual Health Res. doi:10.​1177/​1468794112439086​
30.
Zurück zum Zitat James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Anderson J et al (2009) Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial. Br J Urol Int 103(4):464–469CrossRef James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Anderson J et al (2009) Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial. Br J Urol Int 103(4):464–469CrossRef
31.
Zurück zum Zitat Ritchie J, Spencer L (1994) Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG (eds) Analysing qualitative data. Routledge, London, pp 173–194CrossRef Ritchie J, Spencer L (1994) Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG (eds) Analysing qualitative data. Routledge, London, pp 173–194CrossRef
32.
Zurück zum Zitat Young JM, Muscatello DJ, Ward JE (2000) Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. Brit Jn Urol Int 85:1037–1048CrossRef Young JM, Muscatello DJ, Ward JE (2000) Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. Brit Jn Urol Int 85:1037–1048CrossRef
33.
Zurück zum Zitat Illingworth N, Forbat L, Hubbard G, Kearney N (2010) The importance of relationships in the experience of cancer: a re-working of the policy ideal of whole-systems working. Eur J Oncol Nurs 14(1):23–28PubMedCrossRef Illingworth N, Forbat L, Hubbard G, Kearney N (2010) The importance of relationships in the experience of cancer: a re-working of the policy ideal of whole-systems working. Eur J Oncol Nurs 14(1):23–28PubMedCrossRef
34.
Zurück zum Zitat Chamie K, Kwan L, Connor SE, Zavala M, Labo J, Litwin MS (2012) The impact of social networks and partnership status on treatment choice in men with localized prostate cancer. Br J Urol Int 109(7):1006–1012CrossRef Chamie K, Kwan L, Connor SE, Zavala M, Labo J, Litwin MS (2012) The impact of social networks and partnership status on treatment choice in men with localized prostate cancer. Br J Urol Int 109(7):1006–1012CrossRef
35.
Zurück zum Zitat Campbell C (2001) Social capital and health: contextualising health promotion within local community networks. In: Baron S, Field J, Schuller T (eds) Social capital: critical perspectives. Oxford University Press, Oxford, pp 182–196 Campbell C (2001) Social capital and health: contextualising health promotion within local community networks. In: Baron S, Field J, Schuller T (eds) Social capital: critical perspectives. Oxford University Press, Oxford, pp 182–196
36.
Zurück zum Zitat Mathew AG, Paradiso C, Currie KL, Finelli A, Hartman M et al (2011) Examining risk perception among men with a family history of prostate cancer. Patient Educ Couns 85(2):251–257CrossRef Mathew AG, Paradiso C, Currie KL, Finelli A, Hartman M et al (2011) Examining risk perception among men with a family history of prostate cancer. Patient Educ Couns 85(2):251–257CrossRef
37.
Zurück zum Zitat Boehmer UE, Clark JA (2001) Married couples' perspectives on prostate cancer diagnosis and treatment decision-making. Psycho-Oncology 10(2):147–155PubMedCrossRef Boehmer UE, Clark JA (2001) Married couples' perspectives on prostate cancer diagnosis and treatment decision-making. Psycho-Oncology 10(2):147–155PubMedCrossRef
Metadaten
Titel
The role of interpersonal relationships in men's attendance in primary care: qualitative findings in a cohort of men with prostate cancer
verfasst von
Liz Forbat
Morag Place
Gill Hubbard
Hing Leung
Daniel Kelly
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1989-y

Weitere Artikel der Ausgabe 2/2014

Supportive Care in Cancer 2/2014 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.